Interim report 2026
Filed with HKEX · Stock code 1696 · · 55 pages · English
Earlier from Sisram Medical
- Sisram Medical Delivers Solid 2026 Interim Results
- Sisram Medical to Announce 2026 Interim Results on Wednesday, August 19, 2026
- Sisram Medical Launches Titanium Prime Treatment Concept in Hong Kong SAR
- Sisram Medical Powers Up China EBD Growth Engine with Flagship "黑金牛奶光" Launch
- Sisram Medical's China Manufacturing Facility Commences Operations as First Locally Produced Alma Rejuve Rolls Off the Line
Later from Sisram Medical
- Continuing connected transactions extension of the new sublicense agreement and the new promotional services agreements
- Renewal of continuing connected transactions relating to the new sublicense agreement and the new promotional services agreements
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement share repurchase plan
- Sisram Medical Announces Share Repurchase Plan for Up to 1% of Issued Shares
Follow Sisram Medical into a list and get an email when it puts out news.
Follow Sisram Medical